3-D Matrix Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares 3-D Matrix Ltd with three other
companies in this sector in Japan:
Carna Biosciences Inc
sales of 657.52 million Japanese Yen [US$6.19 million]
BrightPath Biotherapeutics Co Ltd
(529.61 million Japanese Yen [US$4.98 million]
of which 100%
was Commerical Physical Research), and
(365.18 million Japanese Yen [US$3.44 million]
Sales increased substantially in 2017:
3-D Matrix Ltd reported sales of ¥615.85 million (US$5.80 million)
April of 2017.
increase of 334.2%
versus 2016, when the company's sales were ¥141.84 million.